These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18181087)

  • 1. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and lifestyle management in polycystic ovary syndrome.
    Hoeger KM
    Clin Obstet Gynecol; 2007 Mar; 50(1):277-94. PubMed ID: 17304042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome.
    Moran L; Norman RJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):719-36. PubMed ID: 15380143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lifestyle modification in the management of polycystic ovary syndrome.
    Hoeger KM
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL; Buckley JD; Brinkworth GD
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome.
    Nybacka Å; Carlström K; Ståhle A; Nyrén S; Hellström PM; Hirschberg AL
    Fertil Steril; 2011 Dec; 96(6):1508-13. PubMed ID: 21962963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR; Healy DL
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of obesity and adiposity in polycystic ovary syndrome.
    Diamanti-Kandarakis E
    Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polycystic ovary syndrome and obesity: non pharmacological approaches].
    Orio F; Falbo A; Grieco A; Russo T; Oppedisano RM; Sacchinelli A; Giallauria F; Santoro T; Tafuri D; Colao AM; Palomba S
    Minerva Ginecol; 2007 Feb; 59(1):63-73. PubMed ID: 17353875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome in the adolescent.
    Pfeifer SM; Kives S
    Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and the polycystic ovary syndrome.
    Magnotti M; Futterweit W
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.